Suchergebnisse - "Leidner, Rom S"

PubPharm (52)

1

FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment

enthalten in: Cancer immunology research | 2024

von Knorr, D. | Blanchard, L. | Leidner, R. | +14

UpdateOf: bioRxiv. 2023 Jan 20;:. - PMID 36711504

2

Perspectives in Melanoma : meeting report from the Melanoma Bridge (December 1st-3rd, 2022-Naples, Italy)

enthalten in: Journal of translational medicine | 2023

von Ascierto, P. | Agarwala, S. | Warner, A. | +19

3

Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st–3rd, 2022—Naples, Italy)

enthalten in: Journal of translational medicine | 2023

von Ascierto, P. | Agarwala, S. | Warner, A. | +19

4

Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st–3rd, 2022—Naples, Italy)

enthalten in: Journal of translational medicine | 2023

von Ascierto, P. | Agarwala, S. | Warner, A. | +19

5

Cancer's Dark Matter : Lighting the Abyss Unveils Universe of New Therapies

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Fox, B. | Urba, W. | Jensen, S. | +4

CommentIn: Clin Cancer Res. 2023 Jun 13;29(12):2250-2265. - PMID 36749875

6

Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma : RTOG Foundation 3504

enthalten in: International journal of radiation oncology, biology, physics | 2023

von Gillison, M. | Ferris, R. | Harris, J. | +22

7

Development and therapeutic manipulation of the head and neck cancer tumor environment to improve clinical outcomes

enthalten in: Frontiers in oral health | 2022

von Duhen, T. | Gough, M. | Leidner, R. | +1

8

Immune-related adverse events are associated with improved response, progression-free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors

enthalten in: Cancer | 2021

von Foster, C. | Couey, M. | Kochanny, S. | +6

CommentIn: Cancer. 2022 Jul 1;128(13):2549-2550. - PMID 35452127

9

A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection

enthalten in: Oncotarget | 2021

von Sharon, S. | Baird, J. | Bambina, S. | +8

10

Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor

enthalten in: Journal for immunotherapy of cancer | 2021

von Curti, B. | Koguchi, Y. | Leidner, R. | +17

1
2
3
4
5
6
Nächster »
[6]